Format

Send to

Choose Destination
Trends Microbiol. 1998 Mar;6(3):117-24.

Emerging targets for the development of novel antifungal therapeutics.

Author information

1
Immunocompromised Host Section, National Cancer Institute, NIH, Bethesda, MD, USA.

Abstract

Invasive mycoses have become important causes of morbidity and mortality in immunocompromised patients. New approaches for antifungal therapy are required to meet the challenges imposed by these life-threatening infections. Such approaches are being developed through identification of novel biochemical and molecular targets of pathogenic fungi.

PMID:
9582938
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center